comparemela.com

Latest Breaking News On - Beyond air - Page 8 : comparemela.com

Beyond Air To Participate in the Truist Securities BioPharma Symposium

17.10.2023 - GARDEN CITY, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) - Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric . Seite 1

Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH

GARDEN CITY, N.Y., Oct. 16, 2023 Beyond Air, Inc. , a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide to.

Beyond Air Inc (XAIR) Stock: A Value Analysis

Moreover, the 36-month beta value for XAIR is -0.29. Analysts have varying opinions on the stock, with 6 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.” The average price recommended by analysts for Beyond Air Inc (XAIR)

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.